Ispire Technology Inc. (NASDAQ: ISPR) reported fourth quarter and fiscal year 2026 results on September 16, 2026. The vaping technology firm logged Q4 revenue of $26.7 million, a 33% year-over-year increase and a 43% sequential rise.

Full-year operating cash burn improved by $6.8 million to $569,000 in FY26, compared to $7.4 million used in FY25. Management stated that restructuring investments are beginning to translate into improved operating performance.

Financial Performance

Revenue for the three months ended June 30, 2026, rose 43% sequentially from the prior quarter. Gross profit stood at $1.7 million, down from $2.5 million in Q4FY25, resulting in a gross margin contraction to 6.3% from 12.3%. The company attributed the margin decline to inventory impairments recorded during the quarter.

Total operating expenses fell 11.1% to $15.2 million from $17.1 million in the year-ago period. Credit loss expense increased slightly to $9.2 million from $8.6 million. Net loss narrowed to $13.8 million ($0.24 per share) from $14.8 million ($0.26 per share) in Q4FY25.

Adjusted EBITDA loss improved by $2.1 million to ($2.3) million from ($4.4) million in the prior year quarter. Total operating expenses excluding credit loss were $6 million, down 28.6% year-over-year from $8.5 million.

Full Year 2026 Review

For the fiscal year ended June 30, 2026, total revenue declined 24.7% to $96.0 million from $127.5 million in FY25. The decrease was driven by lower cannabis vaping hardware sales in the United States, which fell $17.4 million to $15.1 million, and reduced vaping product sales in Europe, which dropped $12.7 million to $61.4 million.

Gross profit for the full year was $12.3 million, yielding a margin of 12.8%, compared to $22.6 million and 17.8% in FY25. Total operating expenses decreased 26% to $44.9 million from $60.5 million. Full-year net loss improved to ($33.2) million from ($39.2) million.

Total operating expenses excluding credit loss were $24.2 million, down 37% year-over-year from $38.5 million in fiscal 2025. Credit loss for the full year was $20.7 million, down approximately $1.3 million from $22 million in fiscal 2025.

What the Numbers Show

The divergence between rising quarterly revenue and contracting gross margins highlights significant cost pressures. While Q4 revenue grew 33% YoY, gross profit fell 32% due to inventory impairments. This indicates that top-line growth did not translate into operational profitability in the near term, as cost of revenue expanded faster than sales volume.

However, the improvement in operating cash flow is notable. With operating cash used dropping to near break-even levels ($569,000) despite a net loss of $33.2 million, the company demonstrates effective working capital management and cost discipline. The reduction in operating expenses excluding credit losses by 37% YoY suggests the leaner cost structure is providing a stronger foundation for future leverage.

Balance Sheet and Outlook

As of June 30, 2026, Ispire held $19.3 million in cash and working capital of $803,000. Cash increased by $1.3 million sequentially from March 31, 2026.

The company previously expected to achieve cash-flow-positive performance in the second half of calendar year 2026. However, investments related to its Malaysia manufacturing facility during the first quarter of fiscal year 2027 have made the timing less certain. Management remains focused on reaching positive cash flow as new manufacturing and commercial programs scale.

Ispire highlighted multiple growth catalysts, including its fully operational Malaysia manufacturing facility, which offers a 25% tariff advantage over China for US exports. The company obtained its nicotine manufacturing license for vapor products in March 2026 and the license to produce nicotine pouches in May 2026. Management noted strong interest from Chinese brands looking to diversify production and recent visits from major global tobacco companies.

The company is also advancing its Vapor ODM platform and joint venture technologies, including age-gating solutions targeting the US flavored vape market. IKE Tech, the joint venture focused on age verification and product authentication, is pursuing commercial partnerships with large international brands. Management indicated a potential path to a significant liquidity event involving IKE during fiscal 2027 separate from regulatory authorization.

Ispire is also evaluating transformational investments in disruptive technology, seeking opportunities where its capital, manufacturing expertise, or regulatory infrastructure can create meaningful advantage.

Ispire Technology Inc. (NASDAQ: ISPR) appointed Steven Przybyla as its President, effective immediately. The move places a senior, U.S.-based executive in a role designed to speak directly to investors about both Ispire's regulatory strategy and its growth plan.

Przybyla will also continue to serve as the Company's Chief Legal Officer and Secretary. This dual responsibility ensures continuity in legal oversight while expanding his remit to include overall operational leadership as President.